NetTargets utilizes AI-enhanced systems biology and mathematical modeling to provide interpretable predictions for drug discovery, significantly reducing the risk of clinical trial failures. By simulating causal biological networks, the company helps identify effective treatment strategies and optimize patient selection, addressing the high failure rates in drug development.
Funding
$7.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The drug discovery process faces high failure rates, with many clinical trials failing due to a lack of understanding of the relationship between the drug and the disease, or because the wrong patient groups are tested. Traditional drug development methods often treat biological systems as "black boxes," lacking interpretable insights into complex disease mechanisms.
Solution
NetTargets offers an AI-enhanced systems biology platform that provides interpretable predictions for drug discovery, aiming to reduce the risk of clinical trial failures. By simulating causal biological networks, the platform helps identify effective treatment strategies and optimize patient selection. The company's approach integrates multi-disciplinary technologies to convert "black boxes" into "white boxes," unveiling hidden mechanisms of complex biological phenomena. NetTargets' technology enables researchers to explore potential treatment strategies beyond the limitations of traditional experimental methods.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery and development.
Features
- AI-driven analysis of complex biological networks to identify drug targets
- Mathematical modeling to simulate biological processes and predict treatment outcomes
- Causal network simulation to understand and mitigate risks in drug discovery
- Mechanism-based treatment strategy analysis for identifying effective interventions
- Patient selection optimization based on predicted treatment response
- Integration of multi-omics data to build comprehensive biological models